Market Research Logo

Valeant Pharmaceuticals International, Inc. - Strategy, SWOT and Corporate Finance Report

Valeant Pharmaceuticals International, Inc. - Strategy, SWOT and Corporate Finance Report

Summary

Valeant Pharmaceuticals International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Valeant Pharmaceuticals International, Inc. (Valeant or 'the company') is a pharmaceutical company engaged in the development, manufacture and marketing of pharmaceutical products. The company markets a range of pharmaceutical products, medical devices and OTC products primarily in the areas of dermatology, gastrointestinal disorders, eye health and neurology. The key products of the company include contact lenses, intraocular lenses, ophthalmic surgical equipment, aesthetics devices, over-the-counter (OTC) products, gastrointestinal products, dermatological products, and Lotemax Gel. The company markets its products in the North America, Europe, the Middle East, Latin America, Asia Pacific and Africa. Valeant is headquartered in Quebec, Canada.

Scope

  • Detailed information on Valeant Pharmaceuticals International, Inc. required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Valeant Pharmaceuticals International, Inc. in the form of a SWOT analysis
  • An in-depth view of the business model of Valeant Pharmaceuticals International, Inc. including a breakdown and examination of key business segments
  • Intelligence on Valeant Pharmaceuticals International, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Valeant Pharmaceuticals International, Inc., such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
  • Gain understanding of Valeant Pharmaceuticals International, Inc. and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Valeant Pharmaceuticals International, Inc. as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Valeant Pharmaceuticals International, Inc.'s business structure, strategy and prospects.


Company Snapshot
Valeant Pharmaceuticals International, Inc.: Company Overview
Valeant Pharmaceuticals International, Inc.: Overview and Key Facts
Valeant Pharmaceuticals International, Inc.: Overview
Valeant Pharmaceuticals International, Inc.: Key Facts
Valeant Pharmaceuticals International, Inc.: Key Employees
Valeant Pharmaceuticals International, Inc.: Key Employee Biographies
Valeant Pharmaceuticals International, Inc.: Major Products and Services
Valeant Pharmaceuticals International, Inc.: Company History
Valeant Pharmaceuticals International, Inc.: Management Statement
Valeant Pharmaceuticals International, Inc.: Locations and Subsidiaries
Valeant Pharmaceuticals International, Inc.: Key Competitors
Valeant Pharmaceuticals International, Inc.: Company Analysis
Valeant Pharmaceuticals International, Inc.: Business Description
Valeant Pharmaceuticals International, Inc.: SWOT Analysis
Valeant Pharmaceuticals International, Inc.: SWOT Overview
Valeant Pharmaceuticals International, Inc.: Strengths
Valeant Pharmaceuticals International, Inc.: Weaknesses
Valeant Pharmaceuticals International, Inc.: Opportunities
Valeant Pharmaceuticals International, Inc.: Threats
Valeant Pharmaceuticals International, Inc.: Corporate Financial Deals Activity
Valeant Pharmaceuticals International, Inc.: Financial Deals Overview
Valeant Pharmaceuticals International, Inc.: Targets and Partners
Valeant Pharmaceuticals International, Inc.: Top Deals 2014 - 2018YTD*
Valeant Pharmaceuticals International, Inc.: Advisors
Valeant Pharmaceuticals International, Inc.: Top Legal Advisors
Valeant Pharmaceuticals International, Inc.: Top Financial Advisors
Valeant Pharmaceuticals International, Inc.: Mergers and Acquisitions
Valeant Pharmaceuticals International, Inc.: Capital Raising
Valeant Pharmaceuticals International, Inc.: Partnership
Valeant Pharmaceuticals International, Inc.: Divestments
Valeant Pharmaceuticals International, Inc.: Private Equity and Ownership
Valeant Pharmaceuticals International, Inc.: Recent Developments
Valeant Pharmaceuticals International, Inc.: News and Events Summary
Valeant Pharmaceuticals International, Inc.: Corporate Governance
Valeant Pharmaceuticals International, Inc.: Financial Deals
Valeant Pharmaceuticals International, Inc.: Financial Performance
Valeant Pharmaceuticals International, Inc.: Market Developments
Valeant Pharmaceuticals International, Inc.: Regulatory and Legal Events
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: Valeant Pharmaceuticals International, Inc.: Key Facts
Table 2: Valeant Pharmaceuticals International, Inc.: Key Employees
Table 3: Valeant Pharmaceuticals International, Inc.: Locations and Subsidiaries
Table 4: Valeant Pharmaceuticals International, Inc.: Key Competitors
Table 5: Valeant Pharmaceuticals International, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Valeant Pharmaceuticals International, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Valeant Pharmaceuticals International, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Valeant Pharmaceuticals International, Inc.: Targets and Partners
Table 9: Valeant Pharmaceuticals International, Inc.: Top Deals 2014 - 2018YTD*
Table 10: Valeant Pharmaceuticals International, Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Valeant Pharmaceuticals International, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Valeant Pharmaceuticals International, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Valeant Pharmaceuticals International, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Valeant Pharmaceuticals International, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 15: Valeant Pharmaceuticals International, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 16: Valeant Pharmaceuticals International, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: Valeant Pharmaceuticals International, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: Valeant Pharmaceuticals International, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 19: Valeant Pharmaceuticals International, Inc.: Divestments by Geography (2014 - YTD*2018)
Table 20: Valeant Pharmaceuticals International, Inc.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 21: Valeant Pharmaceuticals International, Inc.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 22: Valeant Pharmaceuticals International, Inc.: News and Events Summary
Table 23: Valeant Pharmaceuticals International, Inc.: Corporate Governance
Table 24: Valeant Pharmaceuticals International, Inc.: Financial Deals
Table 25: Valeant Pharmaceuticals International, Inc.: Financial Performance
Table 26: Valeant Pharmaceuticals International, Inc.: Market Developments
Table 27: Valeant Pharmaceuticals International, Inc.: Regulatory and Legal Events
List of Figures
Figure 1: Valeant Pharmaceuticals International, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Valeant Pharmaceuticals International, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Valeant Pharmaceuticals International, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Valeant Pharmaceuticals International, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Valeant Pharmaceuticals International, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Valeant Pharmaceuticals International, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 7: Valeant Pharmaceuticals International, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 8: Valeant Pharmaceuticals International, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 9: Valeant Pharmaceuticals International, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 10: Valeant Pharmaceuticals International, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 11: Valeant Pharmaceuticals International, Inc.: Divestments by Geography (2014 - YTD*2018)
Figure 12: Valeant Pharmaceuticals International, Inc.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 13: Valeant Pharmaceuticals International, Inc.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report